Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 1.81 is 84% below its 5-year average of 11.21, near the low end of its 5-year range (1.81–24.83).
As of the fiscal period ended Tuesday, June 30, 2026. 42.96% below its 12-month average of 3.18.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 1.81.
CURRENT RATIO
1.81
CURRENT RATIO AVG TTM
3.18
CURRENT RATIO AVG 3Y
6.99
CURRENT RATIO AVG 5Y
11.21
CURRENT RATIO AVG 10Y
9.96
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-42.96%
CURRENT VS 3Y AVG
-74.06%
CURRENT VS 5Y AVG
-83.82%
CURRENT VS 10Y AVG
-81.79%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.34
median of 570 covered companies
CURRENT VS SECTOR MEDIAN
-45.79%
vs the sector median at left
Market Cap
$6.82M
Current Ratio
2.61
TTM Avg
3.40
3Y Avg
4.86
5Y Avg
5.09
Market Cap
$7.06M
Current Ratio
45.95
TTM Avg
58.73
3Y Avg
40.89
5Y Avg
40.89
Market Cap
$6.65M
Current Ratio
0.70
TTM Avg
2.00
3Y Avg
1.31
5Y Avg
1.04
Market Cap
$6.53M
Current Ratio
10.21
TTM Avg
3.61
3Y Avg
3.34
5Y Avg
4.20
Market Cap
$7.31M
Current Ratio
1.37
TTM Avg
4.18
3Y Avg
4.61
5Y Avg
4.18
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Co-Diagnostics, Inc. (CODX) | $6.88M | 1.81 | 3.18 | 6.99 | 11.21 |
| Bolt Biotherapeutics, Inc. (BOLT)vs › | $6.82M | 2.61 | 3.40 | 4.86 | 5.09 |
| Aclarion, Inc. (ACON)vs › | $6.80M | 16.20 | 7.76 | 4.60 | 3.08 |
| Curanex Pharmaceuticals Inc Common Stock (CURX)vs › | $7.06M | 45.95 | 58.73 | 40.89 | 40.89 |
| Mangoceuticals, Inc. (MGRX)vs › | $7.22M | 0.18 | 0.90 | 2.08 | 1.78 |
| Ensysce Biosciences, Inc. (ENSC)vs › | $6.65M | 0.70 | 2.00 | 1.31 | 1.04 |
| Enveric Biosciences, Inc. (ENVB)vs › | $6.53M | 10.21 | 3.61 | 3.34 | 4.20 |
| InMed Pharmaceuticals Inc. (INM)vs › | $7.31M | 1.37 | 4.18 | 4.61 | 4.18 |
| KALA BIO, Inc. (KALA)vs › | $7.36M | 6.88 | 3.46 | 4.15 | 4.60 |
| Longeveron Inc. (LGVN)vs › | $7.46M | 2.63 | 4.46 | 3.65 | 4.69 |
Current Ratio
1.81
Quick Ratio
1.52
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 1.81 |
| 2026-03-31 | 2.28 |
| 2025-12-31 | 3.87 |
| 2025-09-30 | 3.81 |
| 2025-06-30 | 4.12 |
| 2025-03-31 | 4.43 |
| 2024-12-31 | 4.41 |
| 2024-09-30 | 6.92 |
| 2024-06-30 | 9.09 |
| 2024-03-31 | 10.19 |
| 2023-12-31 | 10.81 |
| 2023-09-30 | 13.99 |
| 2023-06-30 | 15.13 |
| 2023-03-31 | 23.80 |
| 2022-12-31 | 23.94 |
| 2022-09-30 | 16.95 |
| 2022-06-30 | 17.06 |
| 2022-03-31 | 9.63 |
| 2021-12-31 | 9.14 |
| 2021-09-30 | 24.83 |
| 2021-06-30 | 19.10 |
| 2021-03-31 | 18.37 |
| 2020-12-31 | 16.83 |
| 2020-09-30 | 28.63 |
| 2020-06-30 | 11.57 |
| 2020-03-31 | 16.43 |
| 2019-12-31 | 4.83 |
| 2019-09-30 | 10.02 |
| 2019-06-30 | 14.61 |
| 2019-03-31 | 16.52 |
| 2018-12-31 | 0.45 |
| 2018-09-30 | 1.09 |
| 2018-06-30 | 6.13 |
| 2018-03-31 | 10.98 |
| 2017-12-31 | 7.09 |
| 2017-09-30 | 8.73 |
| 2017-06-30 | 0.07 |
| 2017-03-31 | 0.15 |
| 2016-12-31 | 0.31 |
| 2016-09-30 | 0.07 |
| 2016-06-30 | 0.00 |
| 2016-03-31 | 0.00 |
| 2015-12-31 | 0.15 |
